{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:59:11Z","timestamp":1790830751796,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/08271-7"],"award-info":[{"award-number":["2020\/08271-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["#101086322"],"award-info":[{"award-number":["#101086322"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cell Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejcb.2026.151571","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:53:52Z","timestamp":1788533632000},"page":"151571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the impact of syndecans in prostate cancer: Stage-specific roles and therapeutic implications"],"prefix":"10.1016","volume":"105","author":[{"given":"Ranyelison Silva","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Esaki","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"G\u00f6tte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Oyie Sousa","family":"Onyeisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejcb.2026.151571_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4939-8751-1_6","article-title":"MicroRNAs role in prostate cancer","volume":"1856","author":"Balacescu","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41391-021-00332-5","article-title":"Clinical considerations for the management of androgen indifferent prostate cancer","volume":"24","author":"Berchuck","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ejcb.2026.151571_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-319-95693-0_5","article-title":"MicroRNAs as regulators of prostate cancer metastasis","volume":"1095","author":"Bhagirath","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083724","article-title":"Prognostic significance of deregulated dicer expression in breast cancer","volume":"8","author":"Caffrey","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejcb.2026.151571_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3270001","article-title":"Syndecans: multifunctional cell-surface co-receptors","volume":"327","author":"Carey","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejcb.2026.151571_bib6","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.3390\/ijms25136815","article-title":"Insights into the clinical, biological and therapeutic impact of copy number alteration in cancer","volume":"25","author":"Carey-Smith","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejcb.2026.151571_bib7","doi-asserted-by":"crossref","first-page":"15715","DOI":"10.1074\/jbc.C300430200","article-title":"Syndecan-2 regulates transforming growth factor-\u03b2 signaling","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejcb.2026.151571_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/cells14070547","article-title":"The ceramide-dependent EV secretome differentially affects prostate cancer cell migration","volume":"14","author":"Choezom","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejcb.2026.151571_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.matbio.2010.10.006","article-title":"Syndecans as cell surface receptors: Unique structure equates with functional diversity","volume":"30","author":"Choi","year":"2011","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2012.05.054","article-title":"The role of genetic markers in the management of prostate cancer","volume":"62","author":"Choudhury","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejcb.2026.151571_bib11","first-page":"95","article-title":"Syndecans in the diagnosis and prognosis of prostate cancer","volume":"138","author":"Contreras","year":"2010","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.ejcb.2026.151571_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.urolonc.2009.03.018","article-title":"The expression of syndecan-1 and-2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and \u03b2-catenin, in prostate cancer","volume":"28","author":"Contreras","year":"2010","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ejcb.2026.151571_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/iep.12112","article-title":"Fell-Muir Lecture: Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour","volume":"96","author":"Couchman","year":"2015","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejcb.2026.151571_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/(SICI)1097-4644(19960616)61:4<578::AID-JCB11>3.0.CO;2-C","article-title":"Syndecans, signaling, and cell adhesion","volume":"61","author":"Couchman","year":"1996","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejcb.2026.151571_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejcb.2026.151571_bib16","doi-asserted-by":"crossref","first-page":"40339","DOI":"10.1074\/jbc.M112.405852","article-title":"Loss of receptor protein tyrosine phosphatase \u03b2\/\u03b6 (RPTP\u03b2\/\u03b6) promotes prostate cancer metastasis","volume":"287","author":"Diamantopoulou","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejcb.2026.151571_bib17","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1038\/onc.2012.334","article-title":"Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis","volume":"32","author":"Dong","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejcb.2026.151571_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/his.70033","article-title":"Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis","volume":"88","author":"Dsouza","year":"2026","journal-title":"Histopathology"},{"key":"10.1016\/j.ejcb.2026.151571_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrurol.2012.19","article-title":"Proteoglycans in prostate cancer","volume":"9","author":"Edwards","year":"2012","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejcb.2026.151571_bib20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.surg.2014.08.007","article-title":"Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer","volume":"156","author":"Erler","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ejcb.2026.151571_bib21","series-title":"Global Cancer Observatory: Cancer Today (2024 estimates, version 1.0)","author":"Ervik","year":"2026"},{"key":"10.1016\/j.ejcb.2026.151571_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2019.07.012","article-title":"Role of cell surface proteoglycans in cancer immunotherapy","volume":"62","author":"Espinoza-Sanchez","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biocel.2005.08.012","article-title":"Syndecan-2","volume":"38","author":"Essner","year":"2006","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29829-1","article-title":"The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer","volume":"8","author":"Farf\u00e1n","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejcb.2026.151571_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1158\/1541-7786.MCR-09-0017","article-title":"Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis","volume":"7","author":"Franzen","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejcb.2026.151571_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/boc.201500010","article-title":"Syntenin and syndecan in the biogenesis of exosomes","volume":"107","author":"Friand","year":"2015","journal-title":"Biol. Cell."},{"key":"10.1016\/j.ejcb.2026.151571_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2014.11.056","article-title":"Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer","volume":"456","author":"Fujii","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejcb.2026.151571_bib28","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mc.22381","article-title":"Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer","volume":"55","author":"Fujii","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejcb.2026.151571_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2006.10.006","article-title":"MicroRNA expression and function in cancer","volume":"12","author":"Garzon","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejcb.2026.151571_bib30","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.ejcb.2026.151571_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0974-7788.76794","article-title":"Understanding survival analysis: Kaplan-Meier estimate","volume":"1","author":"Goel","year":"2010","journal-title":"Int. J. Ayurveda Res."},{"key":"10.1016\/j.ejcb.2026.151571_bib32","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1111\/febs.14828","article-title":"Structures and interactions of syndecans","volume":"286","author":"Gondelaud","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.ejcb.2026.151571_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2026.111182","article-title":"Andrographolide targets Syndecan4 to impair its interaction with Syntenin and inhibits the biogenesis of small extracellular vesicles","author":"Gong","year":"2026","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejcb.2026.151571_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fimmu.2020.00227","article-title":"Syndecans in Inflammation at a Glance","volume":"11","author":"Gopal","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejcb.2026.151571_bib35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3390\/cells14201612","article-title":"The role of the cell surface heparan sulfate proteoglycan syndecan-3 in breast cancer pathophysiology","volume":"14","author":"Habenicht","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejcb.2026.151571_bib36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0094-0143(05)70163-4","article-title":"Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience","volume":"28","author":"Han","year":"2001","journal-title":"Urol. Clin. North. Am."},{"key":"10.1016\/j.ejcb.2026.151571_bib37","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3390\/ijms23105793","article-title":"The cell surface heparan sulfate proteoglycan syndecan-3 promotes ovarian cancer pathogenesis","volume":"23","author":"Hillemeyer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejcb.2026.151571_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41588-025-02139-9","article-title":"Spatially resolved transcriptomic analysis of the adult human prostate","volume":"57","author":"Hu","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejcb.2026.151571_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/carcin\/bgs324","article-title":"15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells","volume":"34","author":"Hu","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejcb.2026.151571_bib40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1593\/neo.10586","article-title":"Syndecan-1-dependent suppression of PDK1\/Akt\/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer","volume":"12","author":"Hu","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejcb.2026.151571_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","article-title":"Proteoglycan form and function: A comprehensive nomenclature of proteoglycans","volume":"42","author":"Iozzo","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.20110235","article-title":"p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2","volume":"208","author":"Kim","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejcb.2026.151571_bib43","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2017.75.3657","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial","volume":"36","author":"Kyriakopoulos","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejcb.2026.151571_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40347-7","article-title":"Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression","volume":"13","author":"Lazniewska","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejcb.2026.151571_bib45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/aja.2010.143","article-title":"Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer","volume":"13","author":"Ledezma","year":"2011","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ejcb.2026.151571_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-024-01961-7","article-title":"Epigenetic reader ZMYND11 noncanonical function restricts HNRNPA1-mediated stress granule formation and oncogenic activity","volume":"9","author":"Lian","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejcb.2026.151571_bib47","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3390\/cancers15123215","article-title":"Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1","volume":"15","author":"Logan","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejcb.2026.151571_bib48","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1158\/0008-5472.CAN-24-5018","article-title":"Integrated omics and multicohort analyses identify an enhancer variant linking ferroptosis to precision therapy in prostate cancer","volume":"85","author":"Ma","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejcb.2026.151571_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-025-02170-6","article-title":"Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer","volume":"10","author":"Ma","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejcb.2026.151571_bib50","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1158\/0008-5472.CAN-10-3320","article-title":"HIF induces human embryonic stem cell markers in cancer cells","volume":"71","author":"Mathieu","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejcb.2026.151571_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045480","article-title":"15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival","volume":"7","author":"O\u2019Flaherty","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejcb.2026.151571_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.matbio.2025.02.002","article-title":"Role of syndecan-4 in angiogenesis and vasculogenic mimicry in triple negative breast cancer cells","volume":"136","author":"Onyeisi","year":"2025","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/biom11040503","article-title":"Syndecan-4 as a pathogenesis factor and therapeutic target in cancer","volume":"11","author":"Onyeisi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejcb.2026.151571_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cbin.12158","article-title":"Effects of syndecan-4 silencing on the extracellular matrix remodeling in anoikis-resistant endothelial cells","volume":"48","author":"Onyeisi","year":"2024","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.ejcb.2026.151571_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016617","article-title":"MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis","volume":"6","author":"Otsubo","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejcb.2026.151571_bib56","doi-asserted-by":"crossref","first-page":"e20341.","DOI":"10.1371\/journal.pone.0020341","article-title":"Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT","volume":"6","author":"Peng","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejcb.2026.151571_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214853120","article-title":"Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival","volume":"120","author":"Po\u00e7as","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejcb.2026.151571_bib58","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejcb.2026.151571_bib59","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/febs.12168","article-title":"The heparanase\/syndecan-1 axis in cancer: mechanisms and therapies","volume":"280","author":"Ramani","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ejcb.2026.151571_bib60","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ejcb.2026.151571_bib61","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1111\/febs.17107","article-title":"A biological guide to glycosaminoglycans: current perspectives and pending questions","volume":"291","author":"Ricard-Blum","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.ejcb.2026.151571_bib62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PAT.0000000000000315","article-title":"The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer","volume":"47","author":"Samaratunga","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.ejcb.2026.151571_bib63","first-page":"2112","article-title":"Proteoglycans in prostate cancer progression and therapy resistance","volume":"61","author":"Samar\u017eija","year":"2025","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.ejcb.2026.151571_bib64","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.3390\/ijms22168669","article-title":"Syndecan family gene and protein expression and their prognostic values for prostate cancer","volume":"22","author":"Santos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejcb.2026.151571_bib65","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1349-7006.2009.01174.x","article-title":"Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer","volume":"100","author":"Shimada","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejcb.2026.151571_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110569","article-title":"Genome-wide identification and analysis of prognostic features in human cancers","volume":"38","author":"Smith","year":"2022","journal-title":"Cell. Rep."},{"key":"10.1016\/j.ejcb.2026.151571_bib67","article-title":"Proteoglycan expression in normal human prostate tissue and prostate cancer","volume":"2013","author":"Suhovskih","year":"2013","journal-title":"Int. Sch. Res. Not."},{"issue":"4","key":"10.1016\/j.ejcb.2026.151571_bib68","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejcb.2026.151571_bib69","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pros.23186","article-title":"Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer","volume":"76","author":"Szarvas","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.ejcb.2026.151571_bib70","doi-asserted-by":"crossref","first-page":"312.e9","DOI":"10.1016\/j.urolonc.2018.03.010","article-title":"Circulating syndecan-1 is associated with chemotherapy resistance in castration-resistant prostate cancer","volume":"36","author":"Szarvas","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ejcb.2026.151571_bib71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fonc.2013.00310","article-title":"The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors","volume":"3","author":"Szatm\u00e1ri","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejcb.2026.151571_bib72","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejcb.2026.151571_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2011.10.001","article-title":"Molecular functions of syndecan-1 in disease","volume":"31","author":"Teng","year":"2012","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejcb.2026.151571_bib74","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1002\/cncr.27672","article-title":"Primary cancers before and after prostate cancer diagnosis","volume":"118","author":"Van Hemelrijck","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejcb.2026.151571_bib75","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejcb.2026.151571_bib76","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41588-025-02128-y","article-title":"The landscape of N6-methyladenosine in localized primary prostate cancer","volume":"57","author":"Xu","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejcb.2026.151571_bib77","article-title":"Syndecan-1-induced ECM fiber alignment requires integrin \u03b1v\u03b23 and syndecan-1 ectodomain and heparan sulfate chains","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejcb.2026.151571_bib78","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41419-025-07449-8","article-title":"Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer","volume":"16","author":"Yao","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.ejcb.2026.151571_bib79","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.20615","article-title":"Expression patterns of potential therapeutic targets in prostate cancer","volume":"113","author":"Zellweger","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejcb.2026.151571_bib80","article-title":"An integrated proteomic portrait of prostate cancer progression","volume":"44","author":"Zhang","year":"2025","journal-title":"Cell. Rep."},{"key":"10.1016\/j.ejcb.2026.151571_bib81","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251383634","article-title":"Clinical potential of copy number aberration as a diagnostic and prognostic biomarker in lymphoma","volume":"24","author":"Zhang","year":"2025","journal-title":"Technol. Cancer Res. Treat."}],"container-title":["European Journal of Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933526000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933526000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:36:13Z","timestamp":1790829373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171933526000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0171933526000427"],"URL":"https:\/\/doi.org\/10.1016\/j.ejcb.2026.151571","relation":{},"ISSN":["0171-9335"],"issn-type":[{"value":"0171-9335","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the impact of syndecans in prostate cancer: Stage-specific roles and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejcb.2026.151571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151571"}}